New drug halts growth of aggressive breast cancer in pre-clinical study

A promising drug could lead to a new treatment for the most aggressive form of breast cancer, which affects thousands of women each year. A pre-clinical study led by the University of Adelaide found the new drug successfully inhibits the growth of triple negative breast cancer without any toxic side effects.

Leave A Comment

Your email address will not be published. Required fields are marked *